All lobbying filings

WILLOW LABORATORIES

Lobbying for WILLOW LABORATORIES · technology company

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jun 18, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

California

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 3

Health Issues

Support for coverage and reimbursement for diabetes prevention and wellness technologies; patient safety; support for PBM reform and corporate governance.

Medicare/Medicaid

Support for increased Medicare and Medicaid coverage and reimbursement for diabetes prevention technologies

Financial Institutions/Investments/Securities

corporate governance and transparency

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.